Our Platform Technology
JN Nova Pharma has developed a proprietary therapeutic platform based on a novel enzyme replacement approach designed to restore critical biological pathways disrupted during severe inflammation and tissue injury.
Our platform is designed to:
- Restore biological balance during acute inflammatory injury
- Reduce tissue damage and fibrosis
- Improve lung and organ function
- Address multiple diseases using a single technology platform
- Enable rapid expansion into additional therapeutic indications
The platform has broad potential
The platform has broad potential across respiratory diseases, critical care, fibrosis, viral infections, and biodefense applications.